Maureen F. Morrison - 17 Apr 2023 Form 4 Insider Report for SAFEGUARD SCIENTIFICS INC (SFES)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Apr 2023, 09:07:05 UTC
Prior SEC filing
15 Feb 2023
Next SEC filing
27 Sep 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ G. Matthew Barnard, Agent For: Maureen Morrison

Key filing fact

Maureen F. Morrison filed Form 4 for SAFEGUARD SCIENTIFICS INC (SFES) on 19 Apr 2023.

Key facts

  • This page summarizes Maureen F. Morrison's Form 4 filing for SAFEGUARD SCIENTIFICS INC (SFES).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Apr 2023, 09:07.

Change

  • Previous filing in this sequence was filed on 15 Feb 2023.
  • Current net transaction value: +$17,729.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SFE transaction

common stock

Award

Transaction value
$17,729
Shares
+9,331
Change %
+10%
Price
$1.90
Shares after
100,615
Date
17 Apr 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The securities reported in Table I were awarded to the reporting person in lieu of quarterly fees for service on the Issuer's Board of Directors, which fees are paid in arrears following the end of the quarter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .